Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom and the United States; - subcontracted manufacturing services (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	160K 185K 147K 138K 258K 17.57M 262K 1.74M 677K 8.55M 694K 679K 29.61M	P/E Ratio 2023 *	-	P/E Ratio 2024	-77.6x
Enterprise Value	11.63M 13.47M 10.72M 10.03M 18.8M 1.28B 19.09M 127M 49.34M 623M 50.54M 49.46M 2.16B	EV / Sales 2023	46.6x	EV / Sales 2024	2.39x
Free-Float	95.95%	Yield 2023 *	-	Yield 2024	-

05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan
23-10-16	Safe Orthopaedics Announces Consolidated Sales Results for the Third Quarter and Nine Months of 2023	CI
23-09-06	Safe Group Launches Rehabilitation Proceedings	MT

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE
03-16	SAFE - Modification de la composition du Conseil d'Administration

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Safe Orthopaedics Stock Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news : Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	65.48K
STRYKER CORPORATION	+2.15%	+2.14%	-17.95%	+11.53%	120B
SMITH & NEPHEW PLC	-0.31%	-1.22%	+2.12%	-4.39%	12.9B
GLAUKOS CORPORATION	+2.05%	+1.45%	+29.93%	+89.47%	7.44B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+1.87%	-4.66%	-48.17%	-69.38%	4.2B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.06%	+4.10%	+12.25%	+35.92%	2.55B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+5.46%	+10.04%	-16.99%	-13.15%	1.8B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.67%	-5.73%	+2.23%	-10.20%	1.66B
L&C BIO CO.,LTD	-8.89%	-10.79%	+152.55%	+124.20%	1.37B
Average	+0.59%	+0.88%	+14.50%	+20.50%	18.95B
Weighted average by Cap.	+1.86%	+1.76%	-12.45%	+12.66%

	2023	2024
Net sales	5.81M 6.73M 5.35M 5.01M 9.39M 639M 9.54M 63.22M 24.65M 311M 25.25M 24.71M 1.08B	5.04M 5.84M 4.65M 4.35M 8.15M 555M 8.28M 54.85M 21.39M 270M 21.9M 21.44M 935M
Net income	-205M -238M -189M -177M -332M -22.61B -337M -2.24B -872M -11B -893M -874M -38.1B	-1.93B -2.23B -1.78B -1.66B -3.12B -212B -3.17B -20.99B -8.18B -103B -8.38B -8.2B -358B
Net Debt	270M 313M 249M 233M 437M 29.76B 444M 2.94B 1.15B 14.49B 1.18B 1.15B 50.16B	11.47M 13.28M 10.57M 9.89M 18.54M 1.26B 18.83M 125M 48.66M 614M 49.84M 48.78M 2.13B